Cerenome, Inc. Common Stock (CNSY) Stock Price

CNSYStock
$3.08
Market Cap$23.41M
P/E
PEG Ratio2.45
Div yield
Beta1.77

CNSY Share Price Chart

Favorite Metrics

PEG Ratio2.45
VGM Score29.87

CNSY Earnings Surprise History

Q2 25-0.16est. -3.25
Q3 25-1.00est. -0.88
Q4 250.00est. -0.92
Q1 26-1.05est. -0.87
Q2 26-1.31est. -0.88

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CNSYCerenome, Inc. Common Stock
D$3.08
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Cerenome, Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.